nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Architecture of R&D — a conceptual framework for collaboration
|
Cavalla, David |
|
1997 |
2 |
5 |
p. 200-205 6 p. |
artikel |
2 |
Cambridge Combinatorial
|
Hughes, David |
|
1997 |
2 |
5 |
p. 170- 1 p. |
artikel |
3 |
Combinatorial chemistry
|
|
|
1997 |
2 |
5 |
p. 207-209 3 p. |
artikel |
4 |
Comparison of some major information resources in pharmaceutical competitor tracking
|
Mullen, Alexander |
|
1997 |
2 |
5 |
p. 179-186 8 p. |
artikel |
5 |
Emerging molecular targets
|
Wallace, Robert W. |
|
1997 |
2 |
5 |
p. 207- 1 p. |
artikel |
6 |
High-throughput screening
|
Rogers, Mark V. |
|
1997 |
2 |
5 |
p. 209- 1 p. |
artikel |
7 |
InfoTech Pharma: The information revolution in the pharmaceutical industry
|
Thorne, Matthew |
|
1997 |
2 |
5 |
p. 167-169 3 p. |
artikel |
8 |
Marvellous microplates
|
Leach, Martin |
|
1997 |
2 |
5 |
p. 174-175 2 p. |
artikel |
9 |
Monitor: Molecules and profiles
|
Lloyd, Andrew W. |
|
1997 |
2 |
5 |
p. 206- 1 p. |
artikel |
10 |
Nervous Hawaiian plants
|
Bradley, David |
|
1997 |
2 |
5 |
p. 177- 1 p. |
artikel |
11 |
[No title]
|
Cavalla, David |
|
1997 |
2 |
5 |
p. 178- 1 p. |
artikel |
12 |
[No title]
|
Gardner, Mark |
|
1997 |
2 |
5 |
p. 177-178 2 p. |
artikel |
13 |
Prospects for peptidomimetic drug design
|
Hruby, Victor J. |
|
1997 |
2 |
5 |
p. 165-167 3 p. |
artikel |
14 |
Recent advances in cell adhesion molecules and extracellular matrix proteins: potential clinical implications
|
Mousa, Shaker A. |
|
1997 |
2 |
5 |
p. 187-199 13 p. |
artikel |